Treatment of psoriasis with troglitazone therapy.
Pershadsingh
H A
HA
Sproul
J A
JA
Benjamin
E
E
Finnegan
J
J
Amin
N M
NM
D000328:Adult; D000368:Aged; D002839:Chromans / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone